Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF copper concentrations in chronic schizophrenia.

D Shore, S G Potkin, D R Weinberger

    The American Journal of Psychiatry
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia.

    NPJ schizophrenia·2018
    Same author

    GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium.

    Molecular psychiatry·2017
    Same author

    Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder.

    Molecular psychiatry·2017
    Same author

    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.

    Molecular psychiatry·2017
    Same author

    Investigating the neuroimmunogenic architecture of schizophrenia.

    Molecular psychiatry·2017
    Same author

    Altered expression of histamine signaling genes in autism spectrum disorder.

    Translational psychiatry·2017

    Cerebrospinal fluid (CSF) copper levels did not differ significantly between healthy individuals, former heroin users, and chronic schizophrenic patients. However, schizophrenic women showed lower CSF copper than schizophrenic men.

    Area of Science:

    • Neurochemistry
    • Trace Element Analysis
    • Psychiatric Disorders

    Background:

    • Copper is an essential trace element involved in various neurological processes.
    • Alterations in copper metabolism have been hypothesized to play a role in schizophrenia.
    • Previous research on copper levels in schizophrenia has yielded inconsistent results.

    Purpose of the Study:

    • To investigate cerebrospinal fluid (CSF) copper concentrations in patients with chronic schizophrenia compared to controls.
    • To explore potential differences in CSF copper levels related to sex, heroin addiction, and specific clinical variables in schizophrenia.

    Main Methods:

    • Utilized a sensitive flameless atomic absorption spectrophotometric procedure for precise copper measurement.
    • Analyzed CSF samples from four groups: normal controls, former heroin addicts, unmedicated chronic schizophrenic patients, and medicated chronic schizophrenic patients.

    Related Experiment Videos

  • Collected clinical data including diagnostic subtype, medication status, and demographic information.

    • Main Results:

    • No significant differences in CSF copper levels were observed between the main study groups (controls, former heroin addicts, schizophrenic patients).
    • Schizophrenic women exhibited significantly lower CSF copper levels compared to schizophrenic men.
    • No significant sex differences in CSF copper were found in the control group.
    • CSF copper levels did not correlate with diagnostic subtype, duration of illness, hospitalization length, race, medication status, platelet monoamine oxidase activity, or CAT scan findings.

    Conclusions:

    • CSF copper levels do not appear to be a distinguishing factor between chronic schizophrenia, heroin addiction, and normal controls.
    • A sex-specific difference in CSF copper levels exists in chronic schizophrenia, with women having lower concentrations.
    • These findings suggest that while copper metabolism may be altered in schizophrenia, it is not a primary diagnostic marker across all patient groups or related to common clinical variations.